[CITATION][C] Use of preclinical data for the choice of a Phase II/III dose for evernimicin with application to decision support for identification of a preclinical MIC …

GL Drusano, SL Preston, C Hardalo, R Hare… - Antimicrob Agents …, 2001
Save Cite Cited by 10 Related articles